British pharma bigwig AstraZeneca has admitted that its COVID-19 vaccine can lead to a rare blood clotting condition known as Thrombosis with Thrombocytopenia Syndrome (TTS).
AstraZeneca, in collaboration with the University of Oxford, admits its Covid-19 vaccine can cause a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS). The admission comes amidst a lawsuit alleging severe harm and deaths caused by the vaccine. Kate, wife of a victim, demands an apology and fair compensation after a three-year struggle. The lawsuit, involving fifty-one cases, seeks around £100 million in compensation.
Researchers at the Tata Memorial Hospital in Mumbai have developed a drug that they claim can prevent the resurgence of cancer.
The tablet, named 'R+Cu', contains pro-oxidant tablets with resveratrol and copper, which generate oxygen radicals in the stomach, and cost just around Rs 100.
Only human trials will help understand the efficacy of the new Rs 100 pill developed to prevent recurrence of cancer, said doctors on Wednesday.According to a report by NDTV, researchers at the Tata Memorial Centre (TMC) in Mumbai claimed to .
Human Trials May Reveal Efficacy Of New Rs 100 Cancer Pill: Docs menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.